A new study from the University of Virginia reveals that a widely used class of weight-loss drugs does more than suppress appetite-it directly alters brain circuits that control motivation and reward.

Involving a collaboration with 118 investigators contributing from 89 institutions, scientists from Queen Mary University of ...

Sarah Rutstein, MD, PhD, and Thibaut Davy‑Mendez, PhD, MSPH, with the Institute for Global Health and Infectious Diseases have received an R01 from the National Institute of Mental Health (NIMH) at ...

The review offers important insights for patients and families by explaining why pancreatic cancer has proven so resistant to ...

Among the challenges in treating disease, including cancer, is wiping out malignancies, infection, contaminants or other ...

A type of drug used to prevent migraine may be associated with a reduced risk of glaucoma, according to a study published May ...

Non-concussive head impacts-hits to the head that don't cause clinically detectable symptoms-are correlated with subsequent ...

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have identified a promising new strategy to overcome resistance to immunotherapy in colorectal cancer ...

Researchers at Karolinska Institutet have successfully treated children aged 1–3 years with peanut allergies. The children ...

Three patients with light chain amyloidosis have been treated with CAR T cell therapy in the first European clinical trial testing the safety and efficacy of this immunotherapy in this patient group, ...

Metabolic and bariatric surgery offers significantly greater long-term protection against heart attack, stroke and death than ...

A new trial will test whether a tool that harnesses Apple Watch health data and artificial intelligence can help protect ...